Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TUYA
3751
Tuya Inc
TUYA
$1.03B
| $447K | ﹤0.01% |
270,843
+9,307
| +4% | +$14.2K |
|
3752
Dave Inc
DAVE
$4.74B
| $446K | ﹤0.01% |
11,157
+2,883
| +35% | +$104K |
|
3753
Titan Machinery
TITN
$396M
| $444K | ﹤0.01% |
31,872
+23,637
| +287% | +$354K |
|
3754
Chemung Financial Corp
CHMG
$393M
| $444K | ﹤0.01% |
9,236
+5,788
| +168% | +$271K |
|
3755
Fulcrum Therapeutics
FULC
$273M
| $443K | ﹤0.01% |
124,141
+97,565
| +367% | +$724K |
|
3756
Rigel Pharmaceuticals
RIGL
$681M
| $442K | ﹤0.01% |
27,345
+16,772
| +159% | +$197K |
|
3757
8x8 Inc
EGHT
$269M
| $441K | ﹤0.01% |
216,123
+143,791
| +199% | +$317K |
|
3758
Solid Biosciences
SLDB
$794M
| $438K | ﹤0.01% |
62,856
+50,582
| +412% | +$410K |
|
3759
Hippo Holdings
HIPO
$830M
| $436K | ﹤0.01% |
25,816
+18,960
| +277% | +$341K |
|
3760
Vermilion Energy
VET
$1.82B
| $436K | ﹤0.01% |
44,581
+41,741
| +1,470% | +$424K |
|
3761
Jakks Pacific
JAKK
$301M
| $435K | ﹤0.01% |
17,037
+6,526
| +62% | +$143K |
|
3762
Heron Therapeutics
HRTX
$93.9M
| $435K | ﹤0.01% |
218,455
+50,109
| +30% | +$120K |
|
3763
Viant Technology
DSP
$236M
| $435K | ﹤0.01% |
39,255
+16,784
| +75% | +$179K |
|
|
MAG
3764
DELISTED
MAG Silver
MAG
| $432K | ﹤0.01% |
30,780
+20,899
| +212% | +$275K |
|
|
ITI
3765
DELISTED
Iteris, Inc.
ITI
| $432K | ﹤0.01% |
60,496
+45,265
| +297% | +$270K |
|
|
PSTL
3766
Postal Realty Trust
PSTL
$694M
| $432K | ﹤0.01% |
29,480
+21,506
| +270% | +$309K |
|
3767
Enlight Renewable Energy
ENLT
$11.8B
| $431K | ﹤0.01% |
25,525
+24,942
| +4,278% | +$399K |
|
3768
Biote Corp
BTMD
$68.2M
| $431K | ﹤0.01% |
77,196
+26,510
| +52% | +$177K |
|
3769
SelectQuote
SLQT
$132M
| $430K | ﹤0.01% |
198,357
+124,005
| +167% | +$407K |
|
3770
Cooper-Standard Automotive
CPS
$523M
| $430K | ﹤0.01% |
31,013
+16,284
| +111% | +$226K |
|
|
AZUL
3771
PUT
DELISTED
Azul
AZUL
| $430K | ﹤0.01% |
+125,000
| New | +$470K |
|
3772
Mistras Group
MG
$484M
| $429K | ﹤0.01% |
37,760
+20,482
| +119% | +$210K |
|
3773
SkyWater Technology
SKYT
| $429K | ﹤0.01% |
47,204
+29,523
| +167% | +$246K |
|
3774
Forum Energy Technologies
FET
$708M
| $428K | ﹤0.01% |
27,714
+12,810
| +86% | +$213K |
|
3775
The RealReal
REAL
$1.46B
| $428K | ﹤0.01% |
136,262
+102,759
| +307% | +$309K |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.